ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023 The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Find out more Show/Hide
New test helps drug discoverers identify future cancer treatments 15 Sep 2023 Researchers have developed an investigative procedure that makes the early stages of drug discovery more efficient. Find out more Show/Hide
Scientists create potent ‘degrader’ of cancer-driving protein 26 Apr 2023 Scientists at The Institute of Cancer Research, London, have created a compound that destroys a protein involved in driving cancers, including B-cell lymphoma. Find out more Show/Hide
New personalised cancer medicine company moves in at The London Cancer Hub’s Innovation Gateway 17 Nov 2022
ICR Discovery Club celebrates the second anniversary of the Centre for Cancer Drug Discovery 07 Nov 2022
The Princess Royal officially opens pioneering centre for 'Darwinian' cancer drug discovery 08 Oct 2021